Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro
- PMID: 8255782
- PMCID: PMC310644
- DOI: 10.1093/nar/21.22.5251
Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro
Abstract
Self-cleaving RNAs (ribozymes) can be engineered to cleave target RNAs of choice in a sequence-specific manner (1). Consequently, they could be used to inhibit virus replication or to analyse host gene function in vivo. However, ribozymes that are catalytic in vitro are generally disappointing when analysed in cells unless expressed at high levels relative to their target RNAs (2, 3). Here we provide evidence that this can be overcome by optimizing ribozyme structure using cellular rather than cell-free assays. We show that ribozymes of relatively long flanking complementary regions (FCRs), while poor catalysts in vitro, can produce profound inhibition of HIV replication in cells. By examining a series of ribozymes in which the FCRs vary from 9 to 564 nucleotides, we establish that the optimum length for activity in the cell is > or = 33 nucleotides.
Similar articles
-
Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.Gene. 1994 Nov 4;149(1):33-9. doi: 10.1016/0378-1119(94)90409-x. Gene. 1994. PMID: 7958986
-
Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.Nucleic Acids Res. 1992 Sep 11;20(17):4581-9. doi: 10.1093/nar/20.17.4581. Nucleic Acids Res. 1992. PMID: 1408760 Free PMC article.
-
In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication.RNA Biol. 2011 Mar-Apr;8(2):343-53. doi: 10.4161/rna.8.2.15200. Epub 2011 Mar 1. RNA Biol. 2011. PMID: 21422817
-
The application of ribozymes to HIV infection.Curr Opin Mol Ther. 1999 Jun;1(3):316-22. Curr Opin Mol Ther. 1999. PMID: 11713796 Review.
-
RNA enzymes (ribozymes) as antiviral therapeutic agents.Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x. Trends Biotechnol. 1990. PMID: 1366622 Review.
Cited by
-
Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes.Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1189-94. doi: 10.1073/pnas.95.3.1189. Proc Natl Acad Sci U S A. 1998. PMID: 9448307 Free PMC article.
-
Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.Pharm Res. 1995 Apr;12(4):465-83. doi: 10.1023/a:1016281324761. Pharm Res. 1995. PMID: 7596980 Review.
-
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.RNA. 1997 Jan;3(1):75-88. RNA. 1997. PMID: 8990401 Free PMC article.
-
Strategies for the suppression of peroxidase gene expression in tobacco. I. Designing efficient ribozymes.Transgenic Res. 1996 Jul;5(4):257-62. doi: 10.1007/BF01972879. Transgenic Res. 1996. PMID: 8755165
-
A spermidine-induced conformational change of long-armed hammerhead ribozymes: ionic requirements for fast cleavage kinetics.Nucleic Acids Res. 1997 Dec 1;25(23):4715-22. doi: 10.1093/nar/25.23.4715. Nucleic Acids Res. 1997. PMID: 9365249 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
